Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05865795 · ClinicalTrials.gov registry record
Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 83
- Enrollment target
NCT05865795 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 83 participants.
The verdict
NCT05865795 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
Study using ultrasound of the brain as a diagnostic tool to differentiate between ischemic stroke and hemorrhagic stroke. Correlation of brain perfusion and size of stroke in relation to systemic hemodynamic targets will be assessed on serial scans.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2025-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05865795
The ClinicalTrials.gov registry entry for NCT05865795 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05865795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05865795 about?
NCT05865795 is a clinical study titled "Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes". Study using ultrasound of the brain as a diagnostic tool to differentiate between ischemic stroke and hemorrhagic stroke. Correlation of brain perfusion and size of stroke in relation to systemic hemodynamic targets will be assessed on serial scans.
What is the current status of trial NCT05865795?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2021-10-01. Estimated completion is 2025-02-28.
Who is sponsoring clinical trial NCT05865795?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.